Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
2013 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
2013
The Implications of Obesity for Cardiac Arrhythmia Mechanisms and Management
2014
The risk of acute renal failure in patients with chronic kidney disease
2008
Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?
2005
Long-Term Persistence of Hormonal Adaptations to Weight Loss
2011
Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis
2017
Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome
2005
Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management
2007 Standout
Effects of Glucagon-Like Peptide 1 on Counterregulatory Hormone Responses, Cognitive Functions, and Insulin Secretion during Hyperinsulinemic, Stepped Hypoglycemic Clamp Experiments in Healthy Volunteers
2002
Glucagon-Like Peptide-1 Is Involved in Sodium and Water Homeostasis in Humans
2006
Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery
2005
The complex interaction between obesity, metabolic syndrome and reproductive axis: A narrative review
2012
Intestinal Gluconeogenesis Is a Key Factor for Early Metabolic Changes after Gastric Bypass but Not after Gastric Lap-Band in Mice
2008
Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort
2015
The role of postprandial releases of insulin and incretin hormones in meal-induced satiety—effect of obesity and weight reduction
2001
Electroanatomical Remodeling of the Atria in Obesity
2018
Changes in Diet and Lifestyle and Long-Term Weight Gain in Women and Men
2011 Standout
Effects of liraglutide (NN2211), a long‐acting GLP‐1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes
2005
Association of Common Polymorphisms in GLUT9 Gene with Gout but Not with Coronary Artery Disease in a Large Case-Control Study
2008
Uric Acid and Cardiovascular Risk
2008 Standout
Gut hormones in the control of appetite
2004
The State of US Health, 1990-2010
2013 Standout
The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men
2002
Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters
2005
Gout
2009 Standout
Evidence of a Novel Quantitative-Trait Locus for Obesity on Chromosome 4p in Mexican Americans
2004
Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore
2009
Chronic kidney disease
2011 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Obesity results in progressive atrial structural and electrical remodeling: Implications for atrial fibrillation
2012
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Peripheral signals in the control of satiety and hunger
2003
Next generation tools for the annotation of human SNPs
2009
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study
2015
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Initial sequence of the chimpanzee genome and comparison with the human genome
2005 StandoutNature
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
2018 Standout
Alcohol Consumption and Risk of Atrial Fibrillation
2014
Hyperuricaemia in the Pacific: why the elevated serum urate levels?
2013
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
2012 Standout
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Pericardial Fat Is Associated With Atrial Fibrillation Severity and Ablation Outcome
2011
An Overview of Heart Rate Variability Metrics and Norms
2017 Standout
Chronic kidney disease: global dimension and perspectives
2013 Standout
Epicardial adipose tissue and atrial fibrillation
2014
Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation
2014
Electrophysiological and Hemodynamic Characteristics Associated With Obesity in Patients With Atrial Fibrillation
2012
Alcohol Consumption and Risk of Atrial Fibrillation
2011
Chronic Psychosocial Stress and Hypertension
2010
The Physiology of Glucagon-like Peptide 1
2007 Standout
Shared decision-making in antihypertensive therapy: a cluster randomised controlled trial
2013
What We Talk About When We Talk About Fat
2014 Standout
Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity
2015
Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter
2004
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Normalization of Glucose Concentrations and Deceleration of Gastric Emptying after Solid Meals during Intravenous Glucagon-Like Peptide 1 in Patients with Type 2 Diabetes
2003
Obesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation
2015
Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation
2013
Glycaemic response to foods: Impact on satiety and long-term weight regulation
2007
Ghrelin: Structure and Function
2005 Standout
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
2014 Standout
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
2010 Standout
Relationship of pericardial fat with lipoprotein distribution: The Multi-Ethnic study of atherosclerosis
2015
Glucagon-Like Peptide 1 Induces Natriuresis in Healthy Subjects and in Insulin-Resistant Obese Men
2004
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of a Single-Dose of NN2211, a Long-Acting Glucagon-Like Peptide 1 Derivative, in Healthy Male Subjects
2002
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers
2001
Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2
1999
Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease
2019
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Metabolic Syndrome and Carotid Intima-Media Thickness in Young Adults: Roles of Apolipoprotein B, Apolipoprotein A-I, C-Reactive Protein, and Secretory Phospholipase A2: The Cardiovascular Risk in Young Finns Study
2010
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Tailoring the Approach to Embolic Stroke of Undetermined Source
2019
A Meta-Analysis of the Effect of Glucagon-Like Peptide-1 (7–36) Amide on Ad Libitum Energy Intake in Humans
2001
Decision aids for people facing health treatment or screening decisions
2017 Standout
Potent Derivatives of Glucagon-like Peptide-1 with Pharmacokinetic Properties Suitable for Once Daily Administration
2000
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
The Impact of Obesity on the Cardiovascular System
2018
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation
2009
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential
1999
Therapeutic Strategies Based on Glucagon-Like Peptide 1
2004
Gout
2021 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study
2018
Impact of Surgical Ablation of Atrial Fibrillation on the Progression of Tricuspid Regurgitation and Right‐Sided Heart Remodeling After Mitral‐Valve Surgery: A Propensity‐Score Matching Analysis
2016
Plasma Uric Acid and the Risk of Type 2 Diabetes in a Chinese Community
2007
Intake of Added Sugar and Sugar-Sweetened Drink and Serum Uric Acid Concentration in US Men and Women
2007
Neighborhood Environments and Incident Hypertension in the Multi-Ethnic Study of Atherosclerosis
2016
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation
2018
Associations of Epicardial, Abdominal, and Overall Adiposity With Atrial Fibrillation
2016
Status of Hypertension in China
2018 Standout
Gut hormone PYY3-36 physiologically inhibits food intake
2002 StandoutNature
Components of a Cardioprotective Diet
2011
Obesity is associated with incident atrial fibrillation independent of gender: A meta‐analysis
2018
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of David Conen being referenced
Glucagon-like peptide-1: a potent regulator of food intake in humans
1999
Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country
2004
Twenty-four hour ambulatory blood pressure for the management of antihypertensive treatment: a randomized controlled trial
2008
Novel genetic markers improve measures of atrial fibrillation risk prediction
2013
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial
2017
Alcohol Consumption and Risk of Incident Atrial Fibrillation in Women
2008
Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study
2007
Misconceptions and Facts About Atrial Fibrillation
2015
Long-term comparison of cryoballoon and radiofrequency ablation of paroxysmal atrial fibrillation: A propensity score matched analysis
2014
The Long- and Short-Term Impact of Elevated Body Mass Index on the Risk of New Atrial Fibrillation
2010
Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionals
2009
Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention
2005
Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation
2011
Metabolic Syndrome, Inflammation, and Risk of Symptomatic Peripheral Artery Disease in Women
2009
Predisposing Factors Associated With Development of Persistent Compared With Paroxysmal Atrial Fibrillation
2014
Birth Weight Is a Significant Risk Factor for Incident Atrial Fibrillation
2010
Natriuretic Peptide Precursor A Gene Polymorphisms and Risk of Blood Pressure Progression and Incident Hypertension
2007
Lipoprotein Subclass Abnormalities and Incident Hypertension in Initially Healthy Women
2011
Menopausal age, postmenopausal hormone therapy and incident atrial fibrillation
2017
Heart rate, heart rate variability and inflammatory biomarkers among young and healthy adults
2016
Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women
2009
[Reversible neurological complications in chronic alcohol abuse with hypophosphatemia].
1994